4-Substituted Trinems as Broad Spectrum β-Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity-Reference-Cited by-同舟云学术

4-Substituted Trinems as Broad Spectrum β-Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity

Published:2007-08-01 Issue:17 Volume:50 Page:4113-4121
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Plantan Ivan¹,Selič Lovro¹,Mesar Tomaž¹,Anderluh Petra Štefanič¹,Oblak Marko¹,Preželj Andrej¹,Hesse Lars¹,Andrejašič Miha¹,Vilar Mateja¹,Turk Dušan¹,Kocijan Andrej¹,Prevec Tadeja¹,Vilfan Gregor¹,Kocjan Darko¹,Čopar Anton¹,Urleb Uroš¹,Solmajer Tom¹

Affiliation:

1. Drug Discovery, Lek Pharmaceuticals d.d., Verovskova 57, SI-1526 Ljubljana, Slovenia, National Institute of Chemistry, POB 660, Hajdrihova 19, 1001 Ljubljana, Slovenia, Antibiotic Research Institute, Sandoz, A-1235 Wien, Austria, and Department of Biochemistry and Molecular Biology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0703237

Reference63 articles.

1. The Origin of Plagues: Old and New

2. Inactivation of Antibiotics and the Dissemination of Resistance Genes

3. Beta-lactamases and bacterial resistance to antibiotics

4. Beta-lactamase-mediated resistance and opportunities for its control

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Class C β-Lactamases: Molecular Characteristics;Clinical Microbiology Reviews;2022-09-21

2. Medicinal Chemistry of β‐Lactam Antibiotics;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26

3. Synthesis of Chlorinated, Heteroatom‐Rich and Differently Fused Tricyclic β‐Lactams by Cu(I)‐Catalyzed Halogen Atom Transfer Radical Cyclization;ChemistrySelect;2020-05-28

4. One-Pot Synthesis of Aza-Morita-Baylis-Hillman Adducts via Zinc-Mediated Allylation of 4-Bromocrotonates and Imines;The Journal of Organic Chemistry;2019-10-28

5. 3-Vinylazetidin-2-Ones: Synthesis, Antiproliferative and Tubulin Destabilizing Activity in MCF-7 and MDA-MB-231 Breast Cancer Cells;Pharmaceuticals;2019-04-11